Long-term health checklist after menopause

Menopause itself doesn't require a different screening schedule for most conditions, but the age range it falls in overlaps heavily with when several major screenings become relevant or change. Here's what the US Preventive Services Task Force (USPSTF) currently recommends, with the exact ages and evidence grades.

Breast cancer screening

USPSTF (2024) recommends mammography every 2 years for women aged 40–74 (Grade B — the task force has moderate-to-high certainty of moderate net benefit). For women 75 and older, and for supplemental ultrasound or MRI screening in women with dense breasts, the USPSTF states the current evidence is insufficient to weigh benefits against harms (Grade I) — this doesn't mean screening is wrong at these ages, just that the evidence to make a firm population-level recommendation isn't there yet.

Osteoporosis screening

USPSTF (2025) recommends osteoporosis screening for all women 65 and older (Grade B). Importantly, it also recommends screening postmenopausal women younger than 65 if a clinical risk assessment shows they're at increased fracture risk (also Grade B) — so don't assume you have to wait until 65 if you have risk factors (such as early menopause, low body weight, smoking, or a family history of fracture). Ask your doctor for this risk assessment directly. See our full bone health after menopause guide for more.

Colorectal cancer screening

USPSTF (2021) recommends colorectal cancer screening starting at 45 (Grade B for ages 45–49, Grade A for ages 50–75). For ages 76–85, screening should be offered selectively, factoring in your overall health, prior screening history, and personal preference (Grade C) rather than recommended across the board.

Cervical cancer screening

This is one where many postmenopausal women can actually stop screening, depending on history. USPSTF recommends against continued cervical cancer screening in two specific groups (Grade D, meaning there's at least moderate certainty the service has no net benefit or that harms outweigh benefits):

• Women over 65 who have had adequate prior screening and aren't otherwise at high risk
• Women who have had a hysterectomy with the cervix removed, with no history of a high-grade precancerous lesion or cervical cancer

This isn't a blanket "stop at menopause" rule — it depends on your specific prior screening history and whether your cervix was removed. Confirm with your doctor rather than assuming. One honest caveat: this particular USPSTF topic was marked as having an "update in progress" when we checked, so it's worth confirming you're looking at the current version when you read the full recommendation yourself.

What's covered elsewhere

• Cardiovascular risk (blood pressure, cholesterol, and how HRT factors in): see heart health after menopause
• Unexpected bleeding after menopause, which always needs prompt evaluation regardless of your screening schedule: see postmenopausal bleeding

Prepare for your next checkup

Build a tailored question list for this visit in our treatment conversation builder.